{"denoms":[{"counts":[{"groupId":"BG000","value":"5"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"12"}],"units":"Participants"}],"groups":[{"description":"Patients received celecoxib PO or via feeding tube BID starting 1 to 7 days prior to surgery and continued until the completion of radiation therapy (up to 6 months in total) in the absence of disease progression or unacceptable toxicity.\n\nCelecoxib: Given PO or via feeding tube\n\nQuality-of-Life Assessment: Ancillary studies\n\nQuestionnaire Administration: Ancillary studies","id":"BG000","title":"Celecoxib Arm"},{"description":"Patients received placebo PO or via feeding tube BID starting 1 to 7 days prior to surgery and continued until the completion of radiation therapy (up to 6 months in total) in the absence of disease progression or unacceptable toxicity.\n\nPlacebo: Given PO or via feeding tube\n\nQuality-of-Life Assessment: Ancillary studies\n\nQuestionnaire Administration: Ancillary studies","id":"BG001","title":"Placebo Arm"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"<=18 years"},{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"5"}],"title":"Between 18 and 65 years"},{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"5"},{"groupId":"BG002","value":"7"}],"title":">=65 years"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Age, Categorical","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"7.02","value":"60.40"},{"groupId":"BG001","spread":"20.24","value":"65.14"},{"groupId":"BG002","spread":"15.72","value":"63.17"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"4"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"6"},{"groupId":"BG002","value":"8"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"2"}],"title":"Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"6"},{"groupId":"BG002","value":"10"}],"title":"Not Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Ethnicity (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"American Indian or Alaska Native"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Native Hawaiian or Other Pacific Islander"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"11"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"More than one race"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"5"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"12"}]}],"title":"United States"}],"paramType":"NUMBER","title":"Region of Enrollment","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Gx"},{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"6"}],"title":"G1"},{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"6"}],"title":"G2"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"G3"}]}],"description":"Staging systems are utilized in cancer care to standardize the extent of cancer. The TNM (Tumor, Nodes, Metastasized) system is used for squamous cell carcinomas.\n\nWith this system, G describes the grade of the cancer. The grade score is based on Differentiation (1-Normal cells to 3-Very abnormal cells), Mitotic count (1 to 3; low score means fewer cells were dividing), and Tumor necrosis (0 to 2; lower score means less dying tissue).\n\nThis has possible scores of GX (grade cannot be assessed due to incomplete information), G1 (score of 2-3), G2 (score of 4-5), and G3 (score of 6-8).","paramType":"COUNT_OF_PARTICIPANTS","title":"Initial Histologic Grade","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"4"}],"title":"Stage III"},{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"5"},{"groupId":"BG002","value":"8"}],"title":"Stage IVA"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Stage IVB"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Stage IVC"}]}],"description":"Staging systems are utilized to standardize the extent of cancer, and the TNM (Tumor, Nodes, Metastasized) system is used for squamous cell carcinomas.\n\nThe TNM status is tabulated to give a numerical status from Stage I (T1, N0, and M0) to Stage IVC (any T, any N, and M1).","paramType":"COUNT_OF_PARTICIPANTS","title":"Prognostic Stage","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Hypopharynx"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Larynx"},{"measurements":[{"groupId":"BG000","value":"5"},{"groupId":"BG001","value":"6"},{"groupId":"BG002","value":"11"}],"title":"Oral Cavity"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Oropharynx"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"1"}],"title":"Sinonasal"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Type of Head and Neck Cancer","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"11"}],"title":"Primary"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"}],"title":"Recurrent"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Primary or Recurrent Tumor","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"2"}],"title":"Right"},{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"6"},{"groupId":"BG002","value":"8"}],"title":"Left"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"2"}],"title":"Center/Both"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Laterality","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"}],"title":"pT1"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"2"}],"title":"pT3"},{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"7"}],"title":"pT4a"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"1"}],"title":"rpT4a"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"1"}],"title":"mpT3"}]}],"description":"Staging systems are utilized in cancer care to standardize the extent of the cancer. The TNM (Tumor, Nodes, Metastasized) system is used for bladder cancer.\n\nWith this system, T describes how far the primary tumor has grown and if it has grown into nearby tissue. This staging system ranges from T0 (No evidence of a primary tumor), T4a (tumor has grown beyond a certain point; moderately advanced), to T4b (tumor has grown further than T4a; very advanced).","paramType":"COUNT_OF_PARTICIPANTS","title":"Primary Tumor pT","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"4"}],"title":"pN0"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"}],"title":"pN2a"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"}],"title":"pN2b"},{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"3"}],"title":"pN3b"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"}],"title":"pNx"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"1"}],"title":"N2b"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"1"}],"title":"rpN0"}]}],"description":"Staging systems are utilized in cancer care to standardize the extent of the cancer. The TNM (Tumor, Nodes, Metastasized) system is used for squamous cell carcinomas. With this system, N describes if any cancer spread to lymph nodes.\n\nThis staging system ranges from NX (cannot be assessed), N0 (no regional lymph node spread), N2a (cancer has spread to a single lymph node on the same side of the body as the primary tumor), N2b (cancer has spread to multiple lymph nodes on the same side of the body), to N3b (tumor extends to the supraclavicular fossa).","paramType":"COUNT_OF_PARTICIPANTS","title":"Regional Lymph Nodes pN","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"2"}],"title":"pM0"},{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"6"}],"title":"pMx"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"1"}],"title":"rpMx"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"1"}],"title":"Mx"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"2"}],"title":"Not Applicable"}]}],"description":"Staging systems are utilized in cancer care to standardize the extent of the cancer. The TNM (Tumor, Nodes, Metastasized) system is used for squamous cell carcinomas. With this system, M describes if any cancer spread to other parts of the body.\n\nThis staging system ranges from MX (Cancer spread cannot be assessed), M0 (cancer has not spread), to M1 (cancer has spread).","paramType":"COUNT_OF_PARTICIPANTS","title":"Distant Metastasis pM","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"}],"title":"100 - Normal; no complaints; no evidence of disease"},{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"6"},{"groupId":"BG002","value":"9"}],"title":"90 - Able to carry on normal activity; minor signs or symptoms of disease"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"2"}],"title":"80 - Normal activity with effort; some signs or symptoms of disease"}]}],"description":"Assessment of current activity level was assessed utilizing Karnofsky Performance Status (KPS). The KPS is a scale used to measure a subject's ability to perform daily tasks from 100 Normal no complaints no evidence of disease, 50 Requires considerable assistance and frequent medical care, and 0 Dead.","paramType":"COUNT_OF_PARTICIPANTS","title":"KPS Score","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"1"}],"title":"3 - Tube Dependent (full trials by mouth) - Severe Deficit"},{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"3"}],"title":"5 - Total Oral (multiple texture trials) - Mild Deficit"},{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"5"},{"groupId":"BG002","value":"7"}],"title":"6 - Total Oral (by mouth/restrictions) - Minimal Deficit"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"1"}],"title":"7 - Regular Diet (by mouth/no restrictions) - Normal"}]}],"description":"Assessment of current activity level was assessed utilizing Functional Oral Intake Scale (FOIS).\n\nFOIS is a standardized scale assessed by the treating investigator to determine the functional level of oral intake in patients with dysphagia. The FOIS measures from 1 (Aspirates saliva, Nothing by mouth), 2 (Tube dependent, Nothing by mouth/minimal trials), 3 (Tube dependent, Full trials by mouth), 4 (Total Oral Single, texture trials), 5 (Total Oral, Multiple texture trials), 6 (Total Oral, By mouth/ restrictions Minimal), and 7 (Regular diet, By mouth/ no restrictions).","paramType":"COUNT_OF_PARTICIPANTS","title":"Functional Oral Intake Scale","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"1"}],"title":"Yes"},{"measurements":[{"groupId":"BG000","value":"5"},{"groupId":"BG001","value":"6"},{"groupId":"BG002","value":"11"}],"title":"No"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Feeding Tube","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"8.55","value":"170.68"},{"groupId":"BG001","spread":"11.34","value":"177.66"},{"groupId":"BG002","spread":"10.47","value":"174.75"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Height","unitOfMeasure":"cm"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"20.44","value":"83.12"},{"groupId":"BG001","spread":"21.10","value":"85.63"},{"groupId":"BG002","spread":"19.91","value":"84.58"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Weight","unitOfMeasure":"kg"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"4.95","value":"28.20"},{"groupId":"BG001","spread":"4.83","value":"26.95"},{"groupId":"BG002","spread":"4.69","value":"27.47"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"BMI","unitOfMeasure":"kg/m^2"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"7.70","value":"76.40"},{"groupId":"BG001","spread":"21.43","value":"84.14"},{"groupId":"BG002","spread":"16.97","value":"80.92"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Pulse","unitOfMeasure":"bpm"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"11.92","value":"118.20"},{"groupId":"BG001","spread":"12.39","value":"135.71"},{"groupId":"BG002","spread":"14.72","value":"128.42"}]}],"title":"Systolic"},{"categories":[{"measurements":[{"groupId":"BG000","spread":"6.72","value":"77.20"},{"groupId":"BG001","spread":"7.63","value":"77.71"},{"groupId":"BG002","spread":"6.95","value":"77.50"}]}],"title":"Diastolic"}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Blood Pressure","unitOfMeasure":"mmHg"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"1.41","value":"18"},{"groupId":"BG001","spread":"1.15","value":"16"},{"groupId":"BG002","spread":"1.59","value":"16.83"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Respiratory Rate","unitOfMeasure":"Breaths per Minute"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"0.51","value":"97.98"},{"groupId":"BG001","spread":"0.52","value":"97.98"},{"groupId":"BG002","spread":"0.49","value":"97.98"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Temperature","unitOfMeasure":"Fahrenheit"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"1"}],"title":"Not Assessed"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"1"}],"title":"0) Very Dissatisfied"},{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"3"}],"title":"1) Somewhat dissatisfied"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"2"}],"title":"2) Neutral"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"2"}],"title":"3) Somewhat satisfied"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"3"}],"title":"4) Very satisfied"}]}],"description":"Patient satisfaction was assessed with a pain control questionnaire. The participants were asked how satisfied they were with their overall pain control over the last seven days. Satisfaction was measured from (0) Very Dissatisfied to (4) Very satisfied.","paramType":"COUNT_OF_PARTICIPANTS","title":"Assessment of Overall Pain Control and Management for Patients","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"4"}],"title":"No Pain (0-0.5)"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"3"}],"title":"Mild Pain (0.5-4.4)"},{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"5"}],"title":"Moderate Pain (4.5-7.4)"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Severe Pain (7.5-10)"}],"title":"While at Rest"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"3"}],"title":"No Pain (0-0.5)"},{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"5"}],"title":"Mild Pain (0.5-4.4)"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"2"}],"title":"Moderate Pain (4.5-7.4)"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"2"}],"title":"Severe Pain (7.5-10)"}],"title":"With a Swallow"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"4"}],"title":"No Pain (0-0.5)"},{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"6"}],"title":"Mild Pain (0.5-4.4)"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"}],"title":"Moderate Pain (4.5-7.4)"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"}],"title":"Severe Pain (7.5-10)"}],"title":"With a Cough"}],"description":"Assessment of subjective pain scores on the visual analog scale of pain intensity averaged over a week at rest, with a swallow, and with a cough. The subjects rated their pain from 0-10 on the pain intensity scale. Scores are reported as No Pain (0), Mild Pain (0.5-4.4), Moderate Pain (4.5-7.4), and Severe Pain (7.5-10).","paramType":"COUNT_OF_PARTICIPANTS","title":"Visual Analog Scale","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"24.72","value":"70.0"},{"groupId":"BG001","spread":"33.13","value":"59.52"},{"groupId":"BG002","spread":"29.16","value":"63.89"}]}],"title":"Anxiety (SS)"},{"categories":[{"measurements":[{"groupId":"BG000","spread":"36.35","value":"46.67"},{"groupId":"BG001","spread":"8.40","value":"92.06"},{"groupId":"BG002","spread":"32.64","value":"73.15"}]}],"title":"Body Image (FS)"},{"categories":[{"measurements":[{"groupId":"BG000","spread":"27.89","value":"26.67"},{"groupId":"BG001","spread":"12.60","value":"4.76"},{"groupId":"BG002","spread":"22.29","value":"13.89"}]}],"title":"Coughing (SS)"},{"categories":[{"measurements":[{"groupId":"BG000","spread":"27.39","value":"36.67"},{"groupId":"BG001","spread":"15.85","value":"21.43"},{"groupId":"BG002","spread":"21.71","value":"27.78"}]}],"title":"Dry mouth and sticky saliva (SS)"},{"categories":[{"measurements":[{"groupId":"BG000","spread":"29.81","value":"13.33"},{"groupId":"BG001","spread":"12.60","value":"4.76"},{"groupId":"BG002","spread":"20.72","value":"8.33"}]}],"title":"Neurological Problems (SS)"},{"categories":[{"measurements":[{"groupId":"BG000","spread":"33.33","value":"66.67"},{"groupId":"BG001","spread":"29.99","value":"28.57"},{"groupId":"BG002","spread":"35.77","value":"44.44"}]}],"title":"Opening mouth (SS)"},{"categories":[{"measurements":[{"groupId":"BG000","spread":"27.64","value":"66.67"},{"groupId":"BG001","spread":"26.29","value":"38.10"},{"groupId":"BG002","spread":"29.52","value":"50.00"}]}],"title":"Pain in the head and neck (SS)"},{"categories":[{"measurements":[{"groupId":"BG000","spread":"44.72","value":"46.67"},{"groupId":"BG001","spread":"12.60","value":"95.24"},{"groupId":"BG002","spread":"37.94","value":"75.00"}]}],"title":"Social Contact (FS)"},{"categories":[{"measurements":[{"groupId":"BG000","spread":"27.39","value":"20"},{"groupId":"BG001","spread":"8.13","value":"4.76"},{"groupId":"BG002","spread":"19.25","value":"11.11"}]}],"title":"Problems with senses (SS)"},{"categories":[{"measurements":[{"groupId":"BG000","spread":"21.66","value":"15.56"},{"groupId":"BG001","spread":"8.40","value":"3.17"},{"groupId":"BG002","spread":"15.80","value":"8.33"}]}],"title":"Skin Problems (SS)"},{"categories":[{"measurements":[{"groupId":"BG000","spread":"38.01","value":"53.33"},{"groupId":"BG001","spread":"26.23","value":"19.05"},{"groupId":"BG002","spread":"34.82","value":"33.33"}]}],"title":"Swelling in the neck (SS)"},{"categories":[{"measurements":[{"groupId":"BG000","spread":"27.39","value":"63.33"},{"groupId":"BG001","spread":"20.25","value":"22.62"},{"groupId":"BG002","spread":"30.59","value":"39.58"}]}],"title":"Social Eating (SS)"},{"categories":[{"measurements":[{"groupId":"BG000","spread":"36.70","value":"62.67"},{"groupId":"BG001","spread":"35.43","value":"24.76"},{"groupId":"BG002","spread":"39.44","value":"40.56"}]}],"title":"Speech Problems (SS)"},{"categories":[{"measurements":[{"groupId":"BG000","spread":"35.06","value":"48.33"},{"groupId":"BG001","spread":"18.90","value":"15.48"},{"groupId":"BG002","spread":"30.46","value":"29.17"}]}],"title":"Problems with Swallowing (SS)"},{"categories":[{"measurements":[{"groupId":"BG000","spread":"47.14","value":"50.00"},{"groupId":"BG001","spread":"42.16","value":"66.67"},{"groupId":"BG002","spread":"43.05","value":"59.09"}]}],"title":"Problems with Sexuality (FS)"},{"categories":[{"measurements":[{"groupId":"BG000","spread":"30.02","value":"51.11"},{"groupId":"BG001","spread":"19.25","value":"22.22"},{"groupId":"BG002","spread":"27.40","value":"34.26"}]}],"title":"Problems with teeth (SS)"},{"categories":[{"measurements":[{"groupId":"BG000","spread":"43.46","value":"26.67"},{"groupId":"BG001","spread":"31.71","value":"23.81"},{"groupId":"BG002","spread":"35.18","value":"25"}]}],"title":"Weight loss (SS)"},{"categories":[{"measurements":[{"groupId":"BG000","spread":"29.81","value":"20"},{"groupId":"BG001","spread":"40.50","value":"28.57"},{"groupId":"BG002","spread":"35.18","value":"25.00"}]}],"title":"Problems with Wound Healing (SS)"},{"categories":[{"measurements":[{"groupId":"BG000","spread":"29.81","value":"13.33"},{"groupId":"BG001","spread":"0","value":"0"},{"groupId":"BG002","spread":"19.25","value":"5.56"}]}],"title":"Shoulder Problems (SS)"}],"description":"EORTC QLQ-HN43 is a 43-question survey of health-related quality of life of cancer patients assessing symptoms in the past week from \"1 Not at All\" to \"4 Very Much\".\n\nScores are from 0-100; high scores represent a high response. A high functional scale score (FS; body image, social contact, \\&sexuality) represent a high level of function.\n\nA high symptom scale score (SS; anxiety, cough, pain, swallow, neurologic problems, senses, speech, social eating, weight loss, problems w/ skin, shoulder, wound healing, dry mouth, opening mouth, neck swelling, \\&teeth) represent a high level of symptoms","dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"European Organization for Research &Treatment of Cancer Quality of Life Head & Neck (EORTC QLQ-HN43)","unitOfMeasure":"units on a scale"}]}